OPIATE ANTAGONIST-RECEPTOR INTERACTION UNCHANGED BY ACUTE OR CHRONIC OPIATE TREATMENT

被引:23
作者
DUM, J
BLASIG, J
MEYER, G
HERZ, A
机构
[1] Department of Neuropharmacology, Max-Planck-Institut für Psychiatrie, D-8000 München 40
关键词
Apparent affinity constant of naloxone; Opiate receptors; Opiate tolerance/dependence;
D O I
10.1016/0014-2999(79)90111-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The apparent pA2 of naloxone, a measure of the apparent receptor affinity for the antagonist, was estimated in naive rats, in rats after acute and various schedules of chronic morphine pretreatment, and in rats during abrupt withdrawal. The results were adjusted to compensate for the amount of pretreatment drug in the rat brains as, otherwise, such a drug could have inflated the apparent pA2 values (see appendix). After this adjustment, a tendency of the apparent pA2 values to be increased after chronic pretreatment disappeared. The apparent pA2 of naloxone in acutely pretreated rats was also unchanged from that in naive rats, while the results in abruptly withdrawn rats were ambiguous. Thus, no change in the affinity of the antagonist for opiate receptors was found and theories suggesting that a conformational change takes place in the opiate receptors during the development of tolerance/dependence could not be supported. © 1979.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 20 条
  • [1] BLASIG J, NEUROPHARMACOLOGY
  • [2] BRAIN LEVELS OF MORPHINE IN MICE FOLLOWING REMOVAL OF A MORPHINE PELLET AND NALOXONE CHALLENGE - NO EVIDENCE FOR DISPLACEMENT
    CATLIN, DH
    LIEWEN, MB
    SCHAEFFER, JC
    [J]. LIFE SCIENCES, 1977, 20 (01) : 133 - 139
  • [3] CREESE I, 1975, J PHARMACOL EXP THER, V194, P205
  • [4] QUANTITATIVE-DETERMINATION OF MORPHINE IN BIOLOGICAL SAMPLES BY GAS-LIQUID-CHROMATOGRAPHY AND ELECTRON-CAPTURE DETECTION
    DAHLSTROM, B
    PAALZOW, L
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (03) : 172 - 176
  • [5] INABILITY OF NALOXONE TO CHANGE BRAIN MORPHINE LEVELS IN TOLERANT MICE
    DUM, J
    MEYER, G
    HOLLT, V
    HERZ, A
    CATLIN, DH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 46 (02) : 165 - 170
  • [6] Gibson R D, 1970, J Pharm Sci, V59, P426, DOI 10.1002/jps.2600590338
  • [7] HOFFMEISTER F, 1968, TIEREXPERIMENTELLE U
  • [8] HOLLT V, 1978, FED PROC, V37, P158
  • [9] HOLLT V, 1978, DEV OPIATE RES, P1
  • [10] LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99